AbbVie continues to push innovation with an extensive immunology portfolio with a goal of delivering compelling benefits to more patients around the world.
Take a closer look
Innovation powered by our people
AbbVie has 12,500 research and development team members at the forefront of discovering, developing and delivering therapies to solve unmet patient needs. Our innovation and expertise are powered by leading scientists, whose work continues to pave the way for new generations of researchers – and we all share the goal of identifying therapeutic approaches that have remarkable impacts for patients everywhere.
Our partnerships
Tackling the toughest healthcare challenges requires a dynamic and collaborative approach. That's why we search for meaningful partners across varied disciplines, including more than 220 leading biotechs, universities, nonprofits and governmental organisations. We work together to make our shared vision a reality.
Facing challenges together
More than one million patients worldwide are being treated with AbbVie immunology medicines. And that was made possible by the ~50,000 scientists, researchers, communicators, manufacturing specialists and regulatory experts taking on the toughest health challenges to make a positive impact on people's lives.
April 2023
UK-ABBV-230187
